Age-specific functional epigenetic changes in p21 and p16 in injury-activated satellite cells

Stem Cells

Volumn 33, Issue 3, 2015, Pages 951-961

  Li, Ju ^a   Han, Suhyoun ^a   Cousin, Wendy ^a   Conboy, Irina M ^a  

^a University of California   (United States)

Author keywords

Aging; CDK inhibitor; Chromatin; Epigenetic; MAPK; Muscle stem cells; pERK; Signal transduction; Tissue regeneration

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2B; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P16; PROTEIN P21; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL AGING; CELL COUNT; CELL CYCLE PROGRESSION; CELL DAMAGE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPIGENETICS; GENE CONTROL; GENE LOCUS; GENE SILENCING; HORSE; IMMUNOFLUORESCENCE; MOUSE; MUSCLE INJURY; MUSCLE STEM CELL; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE SATELLITE CELL; STEM CELL NICHE; TIBIALIS ANTERIOR MUSCLE; TISSUE DEGENERATION; WESTERN BLOTTING; AGE; ANIMAL; C57BL MOUSE; GENETIC EPIGENESIS; GENETICS; INJURIES; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE REGENERATION;

AGE FACTORS; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPIGENESIS, GENETIC; GUIDED TISSUE REGENERATION; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION;

EID: 84988268706     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1908     Document Type: Article

References (59)

1. Conboy IM, Conboy MJ, Smythe GM, et al. Notch-mediated restoration of regenerative potential to aged muscle. Science 2003; 302: 1575-1577.
2. Schultz E, Lipton BH,. Skeletal muscle satellite cells: Changes in proliferation potential as a function of age. Mech Ageing Dev 1982; 20: 377-383.
3. Doherty TJ,. Invited review: Aging and sarcopenia. J Appl Physiol (1985) 2003; 95: 1717-1727.
4. Conboy IM, Rando TA,. Aging, stem cells and tissue regeneration: Lessons from muscle. Cell Cycle 2005; 4: 407-410.
5. Conboy IM, Rando TA,. Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches. Cell Cycle 2012; 11: 2260-2267.
6. Yablonka-Reuveni Z,. The skeletal muscle satellite cell: Still young and fascinating at 50. J Histochem Cytochem 2011; 59: 1041-1059.
7. Elabd C, Cousin W, Upadhyayula P, et al. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat Commun 2014; 5: 4082.
8. Weber JD, Cheng J, Raben DM, et al. Ablation of Goalpha overrides G1 restriction point control through Ras/ERK/cyclin D1-CDK activities. J Biol Chem 1997; 272: 17320-17326.
9. Lavoie JN, L'Allemain G, Brunet A, et al. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996; 271: 20608-20616.
10. Chakkalakal JV, Jones KM, Basson MA, et al. The aged niche disrupts muscle stem cell quiescence. Nature 2012; 490: 355-360.
11. Yousef H, Conboy MJ, Li J, et al. hESC-secreted proteins can be enriched for multiple regenerative therapies by heparin-binding. Aging (Albany NY) 2013; 5: 357-372.
12. Fedorov YV, Rosenthal RS, Olwin BB,. Oncogenic Ras-induced proliferation requires autocrine fibroblast growth factor 2 signaling in skeletal muscle cells. J Cell Biol 2001; 152: 1301-1305.
13. Johnson SE, Allen RE,. Activation of skeletal muscle satellite cells and the role of fibroblast growth factor receptors. Exp Cell Res 1995; 219: 449-453.
14. Keshet Y, Seger R,. The MAP kinase signaling cascades: A system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol 2010; 661: 3-38.
15. Campisi J,. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 2005; 120: 513-522.
16. Xiong Y, Hannon GJ, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-704.
17. Ezoe S, Matsumura I, Satoh Y, et al. Cell cycle regulation in hematopoietic stem/progenitor cells. Cell Cycle 2004; 3: 314-318.
18. Sherr CJ, Roberts JM,. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-1512.
19. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287: 1804-1808.
20. Brown JP, Wei W, Sedivy JM,. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277: 831-834.
21. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85: 27-37.
22. Krimpenfort P, Quon KC, Mooi WJ, et al. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001; 413: 83-86.
23. Deng C, Zhang P, Harper JW, et al. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82: 675-684.
24. Brugarolas J, Chandrasekaran C, Gordon JI, et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995; 377: 552-557.
25. Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006; 443: 421-426.
26. Krishnamurthy J, Ramsey MR, Ligon KL, et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443: 453-457.
27. Molofsky AV, Slutsky SG, Joseph NM, et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 2006; 443: 448-452.
28. Stepanova L, Sorrentino BP,. A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress. Blood 2005; 106: 827-832.
29. Sousa-Victor P, Gutarra S, Garcia-Prat L, et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 2014; 506: 316-321.
30. Spivakov M, Fisher AG,. Epigenetic signatures of stem-cell identity. Nat Rev Genet 2007; 8: 263-271.
31. Strahl BD, Allis CD,. The language of covalent histone modifications. Nature 2000; 403: 41-45.
32. Kouzarides T,. Chromatin modifications and their function. Cell 2007; 128: 693-705.
33. Kamminga LM, de Haan G,. Cellular memory and hematopoietic stem cell aging. Stem Cells 2006; 24: 1143-1149.
34. Elabd C, Cousin W, Chen RY, et al. DNA methyltransferase-3-dependent nonrandom template segregation in differentiating embryonic stem cells. J Cell Biol 2013; 203: 73-85.
35. Baylin SB, Ohm JE,. Epigenetic gene silencing in cancer-A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6: 107-116.
36. Liu L, Cheung TH, Charville GW, et al. Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep 2013; 4: 189-204.
37. Rando TA, Chang HY,. Aging, rejuvenation, and epigenetic reprogramming: Resetting the aging clock. Cell 2012; 148: 46-57.
38. Conboy MJ, Conboy IM,. Preparation of adult muscle fiber-associated stem/precursor cells. Methods Mol Biol 2010; 621: 149-163.
39. Nakade K, Pan J, Yamasaki T, et al. JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence. J Biol Chem 2009; 284: 10808-10817.
40. Schreiber M, Kolbus A, Piu F, et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999; 13: 607-619.
41. Iordanskaia T, Nawshad A,. Mechanisms of transforming growth factor beta induced cell cycle arrest in palate development. J Cell Physiol 2011; 226: 1415-1424.
42. Carlson ME, Hsu M, Conboy IM,. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 2008; 454: 528-532.
43. Conboy IM, Conboy MJ, Wagers AJ, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005; 433: 760-764.
44. Conboy IM, Yousef H, Conboy MJ,. Embryonic anti-aging niche. Aging (Albany NY) 2011; 3: 555-563.
45. Gorospe M, Wang X, Holbrook NJ,. Functional role of p21 during the cellular response to stress. Gene Expr 1999; 7: 377-385.
46. Pouyssegur J, Lenormand P,. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem 2003; 270: 3291-3299.
47. Grounds MD,. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann N Y Acad Sci 1998; 854: 78-91.
48. Coqueret O,. Linking cyclins to transcriptional control. Gene 2002; 299: 35-55.
49. Gartel AL, Tyner AL,. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 1999; 246: 280-289.
50. Coleman ML, Marshall CJ, Olson MF,. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J 2003; 22: 2036-2046.
51. Ostrovsky O, Bengal E,. The mitogen-activated protein kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent kinase inhibitor, p21WAF1 protein. J Biol Chem 2003; 278: 21221-21231.
52. Vicent GP, Ballare C, Nacht AS, et al. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol Cell 2006; 24: 367-381.
53. Sassone-Corsi P, Mizzen CA, Cheung P, et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 1999; 285: 886-891.
54. Bernstein BE, Mikkelsen TS, Xie X, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-326.
55. Cui K, Zang C, Roh TY, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009; 4: 80-93.
56. Goldfarb M,. Signaling by fibroblast growth factors: The inside story. Sci STKE 2001; 2001: pe37.
57. Matsumoto T, Turesson I, Book M, et al. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol 2002; 156: 149-160.
58. Wiedlocha A, Sorensen V,. Signaling, internalization, and intracellular activity of fibroblast growth factor. Curr Top Microbiol Immunol 2004; 286: 45-79.
59. Boucher MJ, Jean D, Vezina A, et al. Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2004; 286: G736-746.